Drug Discovery Today, volume 2, issue 9, pages 382-384

Reactive compounds and in vitro false positives in HTS

Rishton Gilbert M. 1
1
 
AMGEN, 1840 DeHavilland Drive, Thousand Oaks, CA 91320, USA. tel: +1 805 447 1064, fax: +1 805 499 5714
Publication typeJournal Article
Publication date1997-09-01
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor7.4
ISSN13596446, 18785832
Drug Discovery
Pharmacology
Abstract
An important component of the successful highthroughput screening (HTS) strategy in drug discovery is the ability to assess HTS structure-activity data, and to distinguish between promising drug leads and the many useless false positives that can plague screening efforts. The author discusses simple chemistry guidelines for the evaluation of ‘positives’ in biochemical screens, with the aim of selecting stable, non-covalent binders (ligands) and eliminating protein-reactive compounds (reagents) from consideration as drug leads at an early stage.

Citations by journals

5
10
15
20
25
30
Journal of Medicinal Chemistry
Journal of Medicinal Chemistry, 30, 10.42%
Journal of Medicinal Chemistry
30 publications, 10.42%
Journal of Chemical Information and Modeling
Journal of Chemical Information and Modeling, 12, 4.17%
Journal of Chemical Information and Modeling
12 publications, 4.17%
Drug Discovery Today
Drug Discovery Today, 11, 3.82%
Drug Discovery Today
11 publications, 3.82%
SLAS Discovery
SLAS Discovery, 10, 3.47%
SLAS Discovery
10 publications, 3.47%
Journal of Computer-Aided Molecular Design
Journal of Computer-Aided Molecular Design, 7, 2.43%
Journal of Computer-Aided Molecular Design
7 publications, 2.43%
Lipophilicity in Drug Action and Toxicology
Lipophilicity in Drug Action and Toxicology, 7, 2.43%
Lipophilicity in Drug Action and Toxicology
7 publications, 2.43%
Methods in Molecular Biology
Methods in Molecular Biology, 7, 2.43%
Methods in Molecular Biology
7 publications, 2.43%
Bioorganic and Medicinal Chemistry Letters
Bioorganic and Medicinal Chemistry Letters, 6, 2.08%
Bioorganic and Medicinal Chemistry Letters
6 publications, 2.08%
Current Opinion in Chemical Biology
Current Opinion in Chemical Biology, 5, 1.74%
Current Opinion in Chemical Biology
5 publications, 1.74%
Bioorganic and Medicinal Chemistry
Bioorganic and Medicinal Chemistry, 5, 1.74%
Bioorganic and Medicinal Chemistry
5 publications, 1.74%
ChemMedChem
ChemMedChem, 5, 1.74%
ChemMedChem
5 publications, 1.74%
Molecular Diversity
Molecular Diversity, 4, 1.39%
Molecular Diversity
4 publications, 1.39%
Nature Chemical Biology
Nature Chemical Biology, 4, 1.39%
Nature Chemical Biology
4 publications, 1.39%
European Journal of Medicinal Chemistry
European Journal of Medicinal Chemistry, 4, 1.39%
European Journal of Medicinal Chemistry
4 publications, 1.39%
Journal of Combinatorial Chemistry
Journal of Combinatorial Chemistry, 4, 1.39%
Journal of Combinatorial Chemistry
4 publications, 1.39%
Journal of Chemical Information and Computer Sciences
Journal of Chemical Information and Computer Sciences, 3, 1.04%
Journal of Chemical Information and Computer Sciences
3 publications, 1.04%
Expert Opinion on Drug Discovery
Expert Opinion on Drug Discovery, 3, 1.04%
Expert Opinion on Drug Discovery
3 publications, 1.04%
Journal of Molecular Graphics and Modelling
Journal of Molecular Graphics and Modelling, 3, 1.04%
Journal of Molecular Graphics and Modelling
3 publications, 1.04%
Methods in Enzymology
Methods in Enzymology, 3, 1.04%
Methods in Enzymology
3 publications, 1.04%
Future Medicinal Chemistry
Future Medicinal Chemistry, 3, 1.04%
Future Medicinal Chemistry
3 publications, 1.04%
Molecules
Molecules, 3, 1.04%
Molecules
3 publications, 1.04%
Scientific Reports
Scientific Reports, 3, 1.04%
Scientific Reports
3 publications, 1.04%
Proteins: Structure, Function and Genetics
Proteins: Structure, Function and Genetics, 3, 1.04%
Proteins: Structure, Function and Genetics
3 publications, 1.04%
Molecular Informatics
Molecular Informatics, 3, 1.04%
Molecular Informatics
3 publications, 1.04%
ACS Medicinal Chemistry Letters
ACS Medicinal Chemistry Letters, 3, 1.04%
ACS Medicinal Chemistry Letters
3 publications, 1.04%
Journal of Natural Products
Journal of Natural Products, 2, 0.69%
Journal of Natural Products
2 publications, 0.69%
Nature Chemistry
Nature Chemistry, 2, 0.69%
Nature Chemistry
2 publications, 0.69%
Medicinal Research Reviews
Medicinal Research Reviews, 2, 0.69%
Medicinal Research Reviews
2 publications, 0.69%
Angewandte Chemie
Angewandte Chemie, 2, 0.69%
Angewandte Chemie
2 publications, 0.69%
5
10
15
20
25
30

Citations by publishers

10
20
30
40
50
60
70
American Chemical Society (ACS)
American Chemical Society (ACS), 66, 22.92%
American Chemical Society (ACS)
66 publications, 22.92%
Elsevier
Elsevier, 57, 19.79%
Elsevier
57 publications, 19.79%
Springer Nature
Springer Nature, 43, 14.93%
Springer Nature
43 publications, 14.93%
Wiley
Wiley, 35, 12.15%
Wiley
35 publications, 12.15%
SAGE
SAGE, 11, 3.82%
SAGE
11 publications, 3.82%
Taylor & Francis
Taylor & Francis, 7, 2.43%
Taylor & Francis
7 publications, 2.43%
Multidisciplinary Digital Publishing Institute (MDPI)
Multidisciplinary Digital Publishing Institute (MDPI), 5, 1.74%
Multidisciplinary Digital Publishing Institute (MDPI)
5 publications, 1.74%
Royal Society of Chemistry (RSC)
Royal Society of Chemistry (RSC), 4, 1.39%
Royal Society of Chemistry (RSC)
4 publications, 1.39%
Future Medicine
Future Medicine, 3, 1.04%
Future Medicine
3 publications, 1.04%
, 2, 0.69%
2 publications, 0.69%
American Society for Pharmacology and Experimental Therapeutics
American Society for Pharmacology and Experimental Therapeutics, 1, 0.35%
American Society for Pharmacology and Experimental Therapeutics
1 publication, 0.35%
Bentham Science
Bentham Science, 1, 0.35%
Bentham Science
1 publication, 0.35%
Frontiers Media S.A.
Frontiers Media S.A., 1, 0.35%
Frontiers Media S.A.
1 publication, 0.35%
Pleiades Publishing
Pleiades Publishing, 1, 0.35%
Pleiades Publishing
1 publication, 0.35%
Universidade De Sao Paulo, 1, 0.35%
Universidade De Sao Paulo
1 publication, 0.35%
The Chemical Society of Japan
The Chemical Society of Japan, 1, 0.35%
The Chemical Society of Japan
1 publication, 0.35%
Walter de Gruyter
Walter de Gruyter, 1, 0.35%
Walter de Gruyter
1 publication, 0.35%
American Association for the Advancement of Science (AAAS)
American Association for the Advancement of Science (AAAS), 1, 0.35%
American Association for the Advancement of Science (AAAS)
1 publication, 0.35%
American Society for Microbiology
American Society for Microbiology, 1, 0.35%
American Society for Microbiology
1 publication, 0.35%
IGI Global
IGI Global, 1, 0.35%
IGI Global
1 publication, 0.35%
Nippon Yakuri Gakkai, 1, 0.35%
Nippon Yakuri Gakkai
1 publication, 0.35%
Thieme
Thieme, 1, 0.35%
Thieme
1 publication, 0.35%
Oxford University Press
Oxford University Press, 1, 0.35%
Oxford University Press
1 publication, 0.35%
10
20
30
40
50
60
70
  • We do not take into account publications that without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Rishton G. M. Reactive compounds and in vitro false positives in HTS // Drug Discovery Today. 1997. Vol. 2. No. 9. pp. 382-384.
GOST all authors (up to 50) Copy
Rishton G. M. Reactive compounds and in vitro false positives in HTS // Drug Discovery Today. 1997. Vol. 2. No. 9. pp. 382-384.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/S1359-6446(97)01083-0
UR - https://doi.org/10.1016%2FS1359-6446%2897%2901083-0
TI - Reactive compounds and in vitro false positives in HTS
T2 - Drug Discovery Today
AU - Rishton, Gilbert M.
PY - 1997
DA - 1997/09/01 00:00:00
PB - Elsevier
SP - 382-384
IS - 9
VL - 2
SN - 1359-6446
SN - 1878-5832
ER -
BibTex |
Cite this
BibTex Copy
@article{1997_Rishton,
author = {Gilbert M. Rishton},
title = {Reactive compounds and in vitro false positives in HTS},
journal = {Drug Discovery Today},
year = {1997},
volume = {2},
publisher = {Elsevier},
month = {sep},
url = {https://doi.org/10.1016%2FS1359-6446%2897%2901083-0},
number = {9},
pages = {382--384},
doi = {10.1016/S1359-6446(97)01083-0}
}
MLA
Cite this
MLA Copy
Rishton, Gilbert M.. “Reactive compounds and in vitro false positives in HTS.” Drug Discovery Today, vol. 2, no. 9, Sep. 1997, pp. 382-384. https://doi.org/10.1016%2FS1359-6446%2897%2901083-0.
Found error?